These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 2547127)

  • 1. Beta-adrenoceptor binding potencies of new aliphatic and alicyclic oxime ethers and their relevance to intraocular pressure control.
    Himber J; Velly J; Kintz P; de Burlet G; Andermann G; Leclerc G
    Methods Find Exp Clin Pharmacol; 1989 May; 11(5):315-21. PubMed ID: 2547127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-653,328: an ocular hypotensive agent with modest beta receptor blocking activity.
    Sugrue MF; Gautheron P; Grove J; Mallorga P; Viader MP; Baldwin JJ; Ponticello GS; Varga SL
    Invest Ophthalmol Vis Sci; 1988 May; 29(5):776-84. PubMed ID: 2896641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological evaluation of ocular beta-adrenoceptors in rabbit by tissue segment binding method.
    Horinouchi T; Morishima S; Tanaka Y; Koike K; Miwa S; Muramatsu I
    Life Sci; 2009 Jan; 84(5-6):181-7. PubMed ID: 19087880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis toxin pretreatment alters agonist binding to beta-adrenoceptors in rabbit ventricular myocardium.
    Akaishi Y; Hattori Y; Kanno M; Sakuma I; Kitabatake A
    Res Commun Mol Pathol Pharmacol; 1994 Aug; 85(2):171-9. PubMed ID: 7994562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quantitative autoradiography with (125I)cyanopindolol of ocular tissues].
    Kahle G; Kaulen P; Wollensak J
    Fortschr Ophthalmol; 1990; 87(1):105-9. PubMed ID: 2157652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenoceptor antagonist activities and binding affinities of timolol enantiomers in rat atria.
    Karhuvaara S; Kaila T; Huupponen R
    J Pharm Pharmacol; 1989 Sep; 41(9):649-50. PubMed ID: 2573714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of beta-adrenoreceptors in vivo with iodine-131 pindolol and gamma scintigraphy.
    Hughes B; Marshall DR; Sobel BE; Bergmann SR
    J Nucl Med; 1986 May; 27(5):660-7. PubMed ID: 3012030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and adrenergic activity of a new series of N-aryl dicyclopropyl ketone oxime ethers: SAR and stereochemical aspects.
    Blanc M; Tamir A; Aubriot S; Michel MC; Bouzoubaa M; Leclerc G; Demenge P
    J Med Chem; 1998 May; 41(10):1613-8. PubMed ID: 9572886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.
    Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Muramatsu I; Nagatomo T
    J Pharm Pharmacol; 2005 Jan; 57(1):75-81. PubMed ID: 15638996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular hypotension in the rabbit. Receptor mechanisms of pirbuterol and nylidrin.
    Mittag TW; Tormay A; Messenger M; Podos SM
    Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):163-9. PubMed ID: 2857689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac beta-adrenergic receptors in diabetic rats: alteration of guanyl nucleotide regulation.
    Cros GH; Chanez PO; Michel A; McNeill JH; Serrano JJ
    J Pharmacol; 1986; 17(4):595-600. PubMed ID: 3031378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of (-) [125I]-iodocyanopindolol binding to rat lung beta adrenoceptors by uremic plasma ultrafiltrates.
    Bree F; Souchet T; Baatard R; Fontenaille C; Lhoste F; Tillement JP
    Biochem Pharmacol; 1987 Oct; 36(19):3121-5. PubMed ID: 2822046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac beta-adrenoceptor binding characteristics with age following adrenal demedullation.
    Tumer N; Houck WT; Boehm C; Roberts J
    Br J Pharmacol; 1990 Jan; 99(1):87-90. PubMed ID: 2158838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and beta-adrenergic blocking activity of new aliphatic and alicyclic oxime ethers.
    Bouzoubaa M; Leclerc G; Decker N; Schwartz J; Andermann G
    J Med Chem; 1984 Oct; 27(10):1291-4. PubMed ID: 6148422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New series of N-substituted phenyl ketone oxime ethers: synthesis and bovine beta3-adrenergic agonistic activities.
    El-Hadri A; Nicolle E; Leclerc G; Pietri-Rouxel F; Strosberg AD; Archimbault P
    Pharmazie; 2003 Jan; 58(1):13-7. PubMed ID: 12622245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the topically effective ocular hypotensive properties of ICI 147,798, a natriuretic beta-adrenoceptor antagonist, in rabbits.
    Kau ST; Limp GL
    Pharmacol Toxicol; 1989 Jan; 64(1):132-6. PubMed ID: 2569189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding potencies of 3 new beta 2 specific blockers to beta receptors in the ciliary processes and the possible relevance of these drugs to intraocular pressure control.
    Trope GE; Clark B
    Br J Ophthalmol; 1984 Apr; 68(4):245-7. PubMed ID: 6142724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do beta-adrenoceptors and serotonin 5-HT1A receptors have similar functions in the control of intraocular pressure in the rabbit?
    Osborne NN; Chidlow G
    Ophthalmologica; 1996; 210(5):308-14. PubMed ID: 8878215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenergic responsiveness of choroidal vasculature.
    Grajewski AL; Ferrari-Dileo G; Feuer WJ; Anderson DR
    Ophthalmology; 1991 Jun; 98(6):989-95. PubMed ID: 1678154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.